Study on enobosarm for weight loss in older adults on semaglutide
Part of Hormones & metabolism clinical trials.
This trial tests if adding enobosarm (a muscle-preserving drug) to semaglutide (a weight-loss medication) can help older adults maintain muscle and improve physical function while losing weight. It may be an option for people who are already taking semaglutide and want to prevent muscle loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 65 or older
- Body mass index (BMI) of 35 or higher, and a maximum weight of 350 pounds
- Currently prescribed semaglutide for weight loss and willing to continue it for about 16 months
- Able to swallow pills and climb stairs for a physical test
- No recent use of other weight-loss medications (like Wegovy or Mounjaro) in the past year
- No serious medical conditions like kidney disease, liver disease, heart rhythm problems, or recent cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding a natural compound called 20E (20-hydroxyecdysone) to the weight-loss drug semaglutide can help people with obesity lose more weight and keep muscle. You would take both medications and follow a diet and exercise plan.
This study tests a new combination of two medications to help older adults with obesity lose weight. It aims to see if adding LUM-201 to semaglutide improves weight loss compared to semaglutide alone.
This study tests a small implant placed under the skin that slowly releases semaglutide, a medication that helps with weight management. It's for people who are overweight but do not have diabetes.
This study tests whether gradually lowering the dose of the weight-loss drug semaglutide can help people who have already lost weight keep it off. You may join if you are already taking weekly semaglutide and have lost at least 10% of your starting weight or are at a healthy weight after losing 5%.
This trial tests whether a lifestyle program (diet and exercise) can help prevent muscle loss in people 65 and older with type 2 diabetes and obesity who are taking semaglutide. It may help you keep your strength and independence while losing weight.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.